Atelocollagen injection alleviates cartilage-related knee pain

  • Lee HS & al.
  • Cartilage
  • 2 Aug 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Intra-articular atelocollagen injection (CartiZol) is simple, safe, and effective for alleviating knee pain from osteoarthritis, chondromalacia, or other cartilage defects.

Why this matters

  • Established osteoarthritis treatments such as corticosteroid and hyaluronic acid (HA) injections relieve pain, but do not repair damaged articular cartilage.

Study design

  • Patients with osteoarthritis or other cartilaginous disease of the knee joint were randomly assigned to receive intra-articular BioCollagen (n=101) or placebo (saline; n=99) in this double-blinded study.
  • Funding: None disclosed.

Key results

  • The BioCollagen vs placebo group showed significantly better visual analogue scale (VAS) scores at 24 weeks (32.11±25.84 vs 41.14±26.01; P=.0147).
  • More patients in the BioCollagen group (vs placebo) reported a greater than 20% (P=.0150) or 40% (P=.0239) improvement in VAS.
  • Total adverse events or rate of occurrence of each adverse event showed no significant difference between the 2 groups.
  • The Western Ontario and McMaster University Osteoarthritis Index, and the 36-item Short-Form Health showed no significant difference between the 2 groups.

Limitations

  •  Long-term effects of pain relief were not observed.

Coauthored with Chitra Ravi, MPharm